International Journal of Radiation Biology · 1999 · 35 citations · 39 references
MedicineCancer BiologyOncologyMolecular OncologyRadiation BiophysicsRadiobiologyBiological Effects Of RadiationCellular Radiation ResponseRadiation BiologyRadiation SensitivityRadiation TherapyApoptosis After IrradiationCancer Cell RadiosensitivityCellular RadiosensitivityG2 Checkpoint ArrestG2/m Checkpoint ControlPoint Mutation EffectsRadiation-induced Cell Cycle ArrestRadiosensitizer Effects
PURPOSE: Bladder cancer cell lines UCRU-BL-13, UCRU-BL-17/2 and UCRU-BL-28, with differing p53 status and molecular responses to irradiation, were used to investigate possible mechanisms for caffeine-induced radiosensitization. MATERIALS AND METHODS: After treatment with caffeine and exposure to X-radiation, radiosensitivity was determined by clonogenic assay. Cell-cycle arrest and apoptosis were measured by flow cytometry. RESULTS: Both BL-13 and BL-28 cells (each expressing p53 with a wild-type sequence) fail to arrest at the G2 checkpoint after radiation, but nevertheless caffeine did induce radiosensitization. In contrast, in BL-17/2 cells (expressing p53 with a point mutation in codon 280), caffeine treatment abrogated the radiation-induced G2 arrest but was not accompanied by radiosensitization. No effects on radiosensitivity were seen in RT112 cells (expressing a functionally defective p53) at low caffeine doses (2 mM), but at higher doses (4 mM and 10 mM) caffeine caused both abrogation of radiation-induced G2 arrest and radiosensitization. In none of the cell lines examined did caffeine treatment and/or irradiation result in apoptosis. CONCLUSIONS: In contrast with previous studies, the data suggest that radiosensitization induced by caffeine is not dependent on abrogation of G2 arrest or the induction of apoptosis, and is not selective for cells expressing p53 proteins with mutations.
39
I. Vermes, C. Haanen, H M Steffens-Nakken et al. · Journal of Immunological Methods · 1995 · 5.4K citations · Full text
Participation of p53 protein in the cellular response to DNA damage.
Michael B. Kastan, Onyinye Onyekwere, D Sidransky et al. · PubMed · 1991 · 3.8K citations
Is a p53-Regulated Inhibitor of G2/M Progression
Heiko Hermeking, Christoph Lengauer, Kornélia Polyák et al. · Molecular Cell · 1997 · 1.2K citations · Full text